RELAPSING POLYCHONDRITIS
Clinical trials for RELAPSING POLYCHONDRITIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING POLYCHONDRITIS trials appear
Sign up with your email to follow new studies for RELAPSING POLYCHONDRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial tests drug options for rare autoimmune disease
Disease control Recruiting nowThis study is testing how well five different standard medications work to control relapsing polychondritis, a rare disease that causes painful inflammation in cartilage. Twenty adults with mild to moderate active disease will try different drug combinations in two stages, starti…
Matched conditions: RELAPSING POLYCHONDRITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists launch major hunt for clues to mysterious cartilage disease
Knowledge-focused Recruiting nowThis study aims to understand how relapsing polychondritis (RP), a rare disease that causes painful inflammation of cartilage, develops and changes over time. Researchers will follow 100 people diagnosed with RP, collecting health information, blood, and urine samples every 6 to …
Matched conditions: RELAPSING POLYCHONDRITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Massive NIH hunt for clues to mysterious, devastating blood vessel diseases
Knowledge-focused Recruiting nowThis study aims to learn more about a group of rare diseases called vasculitis, which cause damaging inflammation in blood vessels. Researchers will follow up to 4,000 people, including patients and healthy volunteers, over many years to track symptoms, collect blood and tissue s…
Matched conditions: RELAPSING POLYCHONDRITIS
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC